A new study from Norwegian biotech company Hofseth BioCare carried out in mice supports the restorative respiratory and immune rebalancing benefits of its full spectrum OmeGo salmon oil.
Salmon oil specialists Biomega is to expand operations by investing in a biorefinery in Denmark that will drive salmon peptide production as the firm sets its sights on the human health and nutrition market.
Norwegian biotech firm Hofseth BioCare (HBC) are to partner up with drug delivery specialists Catalent in an agreement that looks to develop a delayed-release formulation of HBC’s OmeGo salmon oil.
Norways’s Hofseth BioCare (HBC) has expanded its internation distribution deal for its salmon-derived portfolio of ingredients with IMCD, headquartered in the Netherlands.
With its first purchase order from Nestlé-owned Garden of Life in hand, Norwegian biotech company Hofseth BioCare (HBC) is gearing up for significant growth in North America with new products, exciting science, and unique claims.